Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...